Skip to main content

Peer Review reports

From: Impact of immune checkpoint inhibitors (ICIs) therapy on interferon-γ release assay (IGRA) and diagnostic value in non-small cell lung cancer (NSCLC) patients

Original Submission
30 Jul 2023 Submitted Original manuscript
13 Dec 2023 Reviewed Reviewer Report
29 Dec 2023 Reviewed Reviewer Report
9 Feb 2024 Author responded Author comments - Hongni Jiang
Resubmission - Version 2
9 Feb 2024 Submitted Manuscript version 2
19 Feb 2024 Reviewed Reviewer Report
29 Feb 2024 Reviewed Reviewer Report
13 Mar 2024 Author responded Author comments - Hongni Jiang
Resubmission - Version 3
13 Mar 2024 Submitted Manuscript version 3
21 Mar 2024 Author responded Author comments - Hongni Jiang
Resubmission - Version 4
21 Mar 2024 Submitted Manuscript version 4
Publishing
22 Mar 2024 Editorially accepted
12 Apr 2024 Article published 10.1186/s12890-024-02980-4

You can find further information about peer review here.

Back to article page